Skip to main content

Table 4 Descriptive analysis of the studied cases according to different parameters in HCM diagnosis (n = 12)

From: Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?

 

Min.

Max.

Mean

SD

Median

RV EF

49.0

73.0

62.33

8.40

62.50

RV EDV

72.0

217.0

134.9

43.13

134.5

RV ESV

22.0

91.0

52.42

23.09

50.50

RV SV

49.0

126.0

82.17

24.39

79.50

RV EDVI

51.0

114.0

75.83

22.01

73.0

RV ESVI

15.0

48.0

29.42

12.07

24.50

RV SVI

25.0

62.0

45.58

11.0

45.0

LV EF

41.0

80.0

66.42

11.97

68.50

LV EDV

100.0

199.0

143.5

31.77

149.0

LV ESV

21.0

77.0

48.17

16.02

46.50

LV SV

41.0

131.0

98.0

27.78

103.0

LV EDVI

67.0

105.0

80.0

12.47

75.0

LV ESVI

14.0

57.0

27.92

11.57

25.0

LV SVI

33.0

78.0

53.17

11.88

50.50

LV MASS

224,49

94.5

213

88

499

  1. EDV(I) end-diastolic volume (indexed), EF ejection fraction, ESV(I) end-systolic volume (indexed), LV left ventricle, RV right ventricle, SV(I) stroke volume (indexed)